Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Change of heart: Why Pozen now wants to partner its cardiovascular drug
Change of heart: Why Pozen now wants to partner its cardiovascular drug
Change of heart: Why Pozen now wants to partner its cardiovascular drug
Submitted by
admin
on October 5, 2011 - 10:59am
Source:
Med City
News Tags:
Pozen
PA32540
AstraZeneca
GSK
Headline:
Change of heart: Why Pozen now wants to partner its cardiovascular drug
Do Not Allow Advertisers to Use My Personal information
